Peoria, IL 的 前列腺癌 臨床試驗
9 項針對 前列腺癌 的研究正在 Peoria（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距離 9 英里
- Illinois CancerCare-Canton, Canton · 距離 25 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距離 9 英里
- 還有 1 項
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距離 9 英里
- Illinois CancerCare-Canton, Canton · 距離 25 英里
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Illinois Cancer Care ( Site 0104), Peoria
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- OSF Saint Francis Medical Center, Peoria
- Illinois CancerCare-Pekin, Pekin · 距離 9 英里
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距離 9 英里
- 還有 1 項
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距離 9 英里
- 還有 1 項
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
招募中4 期
- Methodist Medical Center of Illinois, Peoria
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- OSF Saint Francis Medical Center, Peoria
- 還有 2 項
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Peoria 的其他研究
- 非小細胞肺癌21 項研究
- 肺癌12 項研究
- 大腸直腸癌12 項研究
- 心臟衰竭8 項研究
- 乳癌8 項研究
- 卵巢癌7 項研究
- 頭頸部鱗狀細胞癌7 項研究
- 轉移性癌症7 項研究
- 胰臟癌7 項研究
- 癌症（所有類型）7 項研究
- 黑色素瘤6 項研究
- 子宮內膜癌6 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。